E-LIB Suche - Ergebnisse für: Karjalainen‐Lindsberg, M‐L - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH RISK DIFFUSE LA..:

Leppä, S ; Jørgensen, J ; Karjalainen‐Lindsberg, M‐L...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

2

Alternative splicing discriminates molecular subtypes and h..:

Leivonen, S-K ; Taskinen, M ; Cervera, A...
Blood Cancer Journal. 7 (2017) 8 - p. e596-e596 , 2017

Link: https://doi.org/10.1038/..

3

Upregulation and differential expression of matrilysin (MMP..:

Salmela, M T ; Karjalainen-Lindsberg, M-L ; Puolakkainen, P.
British Journal of Cancer. 85 (2001) 3 - p. 383-392 , 2001

Link: https://doi.org/10.1054/..

4

Distinct expression profiles of stromelysin-2 (MMP-10), col..:

Puolakkainen, P. ; Vaalamo, M. ; Karjalainen-Lindsberg, M-L....
Gastroenterology. 114 (1998) - p. A1064 , 1998

Link: https://doi.org/10.1016/..

5

Expression of matrix metalloproteinases (MMPs) in peptic ul..:

Puolakkainen, P ; Karjalainen-Lindsberg, M-L ; Vaalamo, M...
Gastroenterology. 108 (1995) 4 - p. A197 , 1995

Link: https://doi.org/10.1016/..

6

Alternative splicing discriminates molecular subtypes and h..:

Leivonen, S-K ; Taskinen, M ; Cervera, A...
10.1038/bcj.2017.71. , 2017

Link: http://hdl.handle.net/10..

7

Alternative splicing discriminates molecular subtypes and h..:

Leivonen, S-K ; Taskinen, M ; Cervera, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596382/. , 2017

Link: http://www.ncbi.nlm.nih...

8

Upregulation and differential expression of matrilysin (MMP..:

Salmela, M T ; Karjalainen-Lindsberg, M-L ; Puolakkainen, P.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364078. , 2001

Link: http://www.ncbi.nlm.nih...

1-8